Frontlight ResearchEarly access
Trial site
University College Hospitals NHS Foundation Trust
- 1running trial
- 3closed trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Stroke2 trials
- Acute myeloid leukaemia1 trial
- Antiphospholipid syndrome1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Liver and biliary tract cancer1 trial
- Lupus (SLE)1 trial
- Mantle cell lymphoma1 trial
- and 3 more
- Phase
- Phase 22 trials
- Phase 41 trial
- Status
- Completed3 trials
- Active, not recruiting1 trial
- Lead sponsor
- University College, London2 trials
- Pharmacyclics Switzerland GmbH1 trial
- Redx Pharma Ltd1 trial
Running trials
Active, not recruiting
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026